I agree,
I was wondering what was going on when I first saw it as the email
neither asked nor answered a question, but just gave some unasked for
information, without any references.
Dan
****************************************************************************
Dan Mayer, MD
Professor of Emergency Medicine
Albany Medical College
47 New Scotland Ave.
Albany, NY, 12208
Ph; 518-262-6180
FAX; 518-262-5029
E-mail; [log in to unmask]
****************************************************************************
>>> Rakesh Biswas <[log in to unmask]> 07/21/07 5:08 AM >>>
Yes even I was wondering why it was posted to this list.
rakesh
On 7/21/07, k.hopayian <[log in to unmask]> wrote:
>
> This looks like a commercial posting. It does not add to the
discussion on
> EBP, add to our understanding of it or ask/contribute to
collaboration. I
> would like to know what others on this list think about such postings.
>
>
> --
> B/W, Kev Hopayian
> -------on 20/7/07 11:14, Jane McHugh at [log in to unmask] wrote:
>
> *Evidence still lacking on how fast antidepressants act*
>
> One of the most important questions about antidepressant drugs - how
> quickly they act - remains unanswered, say mental health experts
today.
>
> In an editorial for BMJ Clinical Evidence, Andrea Cipriani and
colleagues
> say that the speed people respond to these drugs has great clinical
> relevance for both the patient and the physician, but conclusive
evidence is
> still lacking.
>
> For instance, a shorter response time rapidly improves patient
wellbeing,
> decreasing length of hospitalisation, and reducing the amount of time
the
> patient spends away from work, and the time the impairment affects
family
> and friends. It also enables physicians to make prompt decisions about
> changing or optimising treatment.
>
> Views have changed over the years, but recent studies indicate that
these
> drugs act quickly rather than having a delayed effect.
>
> However, there are many challenges involved in designing studies to
detect
> timing of onset, say the authors. For example, how to measure and
define an
> early response and what degree of symptom reduction is needed to
fulfil this
> definition.
>
> They also point to financial incentives surrounding fast acting
> antidepressants, and warn clinicians to ensure that fast onset of
action is
> not valued at the expense of tolerability or long-term effectiveness
of
> antidepressant treatment.
>
> Ends
> *
> Note to editors:*
> BMJ Clinical Evidence is an international peer reviewed medical
journal,
> published by the BMJ Group. In addition, BMJ Clinical Evidence
provides an
> invaluable set of evidence based medicine facilities to help busy
clinicians
> manage their patients as effectively as possible. It sums up what's
known -
> and not known - about more than 3000 interventions and 540 clinical
> questions and is one of the world's most trusted and effective sources
of
> medical evidence for clinical decisions.
>
> Further information from:
> Shannon Amoils, Clinical Editor, BMJ Clinical Evidence
> Tel: 0207 383 6737
> Email: [log in to unmask]
> *www.clinicalevidence.co.uk* <www.clinicalevidence.co.uk
> www.clinicalevidence.co.uk>
>
> Click here to view full editorial: *
> http://press.psprings.co.uk/bmj/july/Cipriani.doc*
>
<http://press.psprings.co.uk/bmj/july/Cipriani.doc><http://press.psprings.co.uk/bmj/july/Cipriani.doc>
>
>
>
>
>
>
>
>
>
>
> ----------------------------------------------------
> Jane McHugh, Information Specialist
> BMJ Knowledge, BMJ Group
> BMA House, Tavistock Square, London WC1H 9JR
> Tel: 020 7383 6384 Fax: 020 7383 6242
>
> http://www.clinicalevidence.com
> http://www.besttreatments.co.uk
>
>
> **********************************************************************
> This email and any files transmitted with it are confidential and
> intended solely for the use of the individual or entity to whom they
> are addressed. If you have received this email in error please notify
> [log in to unmask]
>
> **********************************************************************
>
_______________________________________________________________________
>
> This email and any attachments are confidential and intended solely
for
> the addressee. They may not be disclosed to, used by or copied in any
way by
> anyone other than the intended recipient. If you have received this
email in
> error please notify [log in to unmask] and delete the email
> transmission immediately.
>
> Any views expressed in this email are those of the individual and may
not
> represent those of the BMJ Publishing Group Ltd.
>
> Computer viruses can be transmitted by email. The recipient should
check
> this email and any attachments for presence of viruses.The BMJ
Publishing
> Group Ltd accepts no liability for damage caused by any virus
transmitted by
> this email. Emails sent or received by the BMJ Publishing Group are
> monitored.
>
> BMJ Publishing Group Limited
> A private limited company, registered in England and Wales under
> registered number 03102371
> Registered office: BMA House, Tavistock Square, London WC1H 9JR, UK.
> http://bmjgroup.bmj.com
>
_______________________________________________________________________
>
>
>
>
>
>
-----------------------------------------
CONFIDENTIALITY NOTICE: This email and any attachments may contain
confidential information that is protected by law and is for the
sole use of the individuals or entities to which it is addressed.
If you are not the intended recipient, please notify the sender by
replying to this email and destroying all copies of the
communication and attachments. Further use, disclosure, copying,
distribution of, or reliance upon the contents of this email and
attachments is strictly prohibited. To contact Albany Medical
Center, or for a copy of our privacy practices, please visit us on
the Internet at www.amc.edu.
|